Support for the Management of Parental Stress in Surgical Resuscitation of Congenital Heart Diseases

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-28
SponsorUniversity Hospital, Bordeaux

About this trial

Half of children with congenital heart disease develop specific neurodevelopmental disorders. Neurodevelopmental disorders are the leading cause of morbidity in these children. They can be increased by perioperative complications, the family and economic socio-economic environment and the level of parental stress. The stress perceived by parents of children with congenital heart disease varies depending on the time of diagnosis, the organization of care inherent in neonatal management and the type of pathology diagnosed.

The main objective is to evaluate the feasibility of a multidisciplinary and personalised model of support for parental stress, from the ante-natal period, in the context of their child's neonatal cardiac surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Parents whose fetus has congenital heart disease diagnosed in antenatal, which will be operated in the neonatal period (between 0 and 28 days of life) within our sector.

Parents followed in the congenital heart disease sector of the University Hospital of Bordeaux as soon as the diagnosis is announced in antenatal.

Free, informed and signed written consent of the couple or single mother in a single parent setting or by a third person (in case of physical disability of the participant) and the investigator (no later than the day of inclusion and before any examination required by the research).

Person affiliated or beneficiary of a social security scheme (excluding AME).

Disqualifiers

Parents who do not understand or read French and cannot be accompanied by a third party for translation.

Parents with major psychiatric disorders.

Parents deprived of liberty due to ongoing legal proceedings.

Parents under guardianship or curatorship or unable to personally express consent.

Trial design

Design model

Single group

Treatments tested in this trial

  • Personalized support project

    Other intervention

    1. Presence of a child nurse at the consultation of the anesthesiologist-resuscitator. 2. Antenatal paramedical consultation conducted by a child nurse composed of a semi-structured interview and an evaluation of Parental Stress by the ISP-4 self-questionnaire. 3. Implementation of the personalized support project 4. Self-assessment of parental stress using the ISP-4 self-questionnaire (child admitted to intensive care or resuscitation unit) 5. Application of the personalised support project 6. Self-assessment of parental stress using the ISP-4 self-questionnaire (child discharged from intensive care) 7. Paramedical follow-up consultation with parents (semi-directive interview, ISP-4 self-questionnaire) and assessment of the child's psychomotor development in the child's 6th month of life

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Accompaniment projectExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Families participation evaluation

The participation of families in the proposed accompaniment will be evaluated by the participation rate: number of parents who participated in the study until the last stage of the protocol, number of parents who dropped out of the study and reason.

Time frame
at the last protocol visit ( visit 6 - day 180)

Secondary outcomes

1

Parental stress Evolution

Evolution of parental stress by the ISP-4 self-questionnaire (Parental Stress Index)

Time frame
between visit 1 (day -28) and visit 6 (day 180)
2

Infant development

Evolution of the overall score of the Bayley-4 scale (Bayley Infant and Young Child Development Scales) at 6 months of life compared to a literature cohort (neonate child).

Time frame
at the last protocol visit ( visit 6 - day 180)
3

Evaluation of the healthcare team adherence

Evaluation of the adherence of the healthcare team to this new model via a Likert scale administered at the discharge of the child, and an analysis of the large items found on the accompanying sheets

Time frame
at visit 5 ( day 60 )
4

Evaluation of the healthcare team adherence

Evaluation of the adherence of the healthcare team to this new model via an EVA scale administered at the discharge of the child, and an analysis of the large items found on the accompanying sheets

Time frame
at visit 5 ( day 60 )

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.